14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $51.99 $51.99 Friday, 27th Jan 2023 CCXI stock ended at $51.99. During the day the stock fluctuated 0% from a day low at $51.99 to a day high of $51.99.
90 days $51.99 $51.99
52 weeks $14.95 $52.00

Historical ChemoCentryx prices

Date Open High Low Close Volume
Feb 05, 2020 $45.81 $47.16 $45.50 $47.16 521 425
Feb 04, 2020 $45.57 $45.90 $44.60 $45.26 800 727
Feb 03, 2020 $42.88 $44.96 $42.59 $44.89 649 338
Jan 31, 2020 $40.70 $42.47 $40.42 $42.42 389 997
Jan 30, 2020 $39.92 $41.41 $39.66 $40.90 285 923
Jan 29, 2020 $41.23 $41.58 $40.31 $40.75 248 484
Jan 28, 2020 $41.10 $42.04 $40.81 $41.17 260 703
Jan 27, 2020 $39.80 $41.07 $38.85 $40.62 403 096
Jan 24, 2020 $41.47 $43.08 $40.35 $41.27 576 816
Jan 23, 2020 $42.53 $42.84 $39.46 $40.74 636 634
Jan 22, 2020 $43.13 $43.93 $42.09 $42.52 832 365
Jan 21, 2020 $43.44 $44.21 $41.51 $42.72 938 539
Jan 17, 2020 $40.98 $43.89 $40.36 $43.66 1 423 350
Jan 16, 2020 $38.00 $41.17 $37.94 $40.93 1 301 594
Jan 15, 2020 $37.91 $38.88 $37.16 $37.65 566 913
Jan 14, 2020 $36.73 $38.50 $36.22 $37.91 472 171
Jan 13, 2020 $38.00 $38.19 $36.22 $36.69 618 408
Jan 10, 2020 $38.36 $39.10 $38.04 $38.21 847 095
Jan 09, 2020 $36.83 $38.88 $36.40 $38.47 899 843
Jan 08, 2020 $35.34 $37.23 $35.10 $36.79 563 064
Jan 07, 2020 $34.82 $35.88 $33.91 $35.39 633 756
Jan 06, 2020 $35.64 $35.89 $33.84 $34.77 740 501
Jan 03, 2020 $36.05 $36.50 $35.11 $35.95 672 680
Jan 02, 2020 $39.57 $39.80 $35.81 $36.44 853 690
Dec 31, 2019 $37.92 $39.75 $37.63 $39.55 959 209
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT